Professional overview
Dr. Hou Li is a Chief Physician and Associate Professor at Dongzhimen Hospital, specializing in integrative medicine for malignant tumors and hematologic disorders.
Department leadership
A department head is an organisational role. “Chief Physician” is a clinical rank; the two are listed separately.
Areas of focus
Background
- 2004Published research on traditional Chinese medicine reversal of multidrug resistance in tumors
- 2005Published studies on dioscin’s effect on breast cancer cell cycle and on uconitine’s mechanism against drug-resistant squamous carcinoma cells
- 2006Published retrospective clinical study on traditional Chinese medicine use during peri-chemotherapy period in advanced non-small cell lung cancer
- 2007Published retrospective clinical study on syndrome patterns in advanced non-small cell lung cancer
- 2011Published research on traditional Chinese medicine intervention for lung cancer angiogenesis and on cancer-related anemia treatment (as corresponding author)
Experience & recognition
- Participated in over 20 research projects
- Principal investigator of Beijing Municipal Science and Technology Development Fund project on independent innovation
- Core member of National Key Technologies R&D Program (Eleventh Five-Year Plan) project on TCM intervention for refractory acute leukemia during peri-chemotherapy
- Core member of National Natural Science Foundation of China (NSFC) project on cellular and molecular mechanisms of tea polyphenols in inhibiting tumor angiogenesis
- Core member of Ministry of Science and Technology (MOST) major special project on development of hospital preparation 'Yi Sui Granules'
- Co-inventor of 2 patents
- Backbone leader of the State Administration of Traditional Chinese Medicine key discipline 'Traditional Chinese Medicine Internal Medicine Hematology'
- Recipient of China Association of Integrative Medicine Science and Technology Award (Third Prize) for research on tea polyphenols and tumor angiogenesis
- Recipient of China Academy of Traditional Chinese Medicine Science and Technology Award (Third Prize) for clinical and basic research on 'Yi Sui Granules' in myelodysplastic syndrome
- Recipient of Beijing University of Chinese Medicine Science and Technology Award (Third Prize) for research on aconitine’s mechanism against drug-resistant squamous carcinoma cells
Professional roles
- Member, Beijing Society of Integrative Medicine, Oncology Branch
- Member, Beijing Anti-Cancer Association, Integrated Traditional Chinese and Western Medicine Branch
- Editor, Chinese Journal of Clinical Physicians
Frequently asked questions
What does Dr. Hou Li specialize in?
Specializes in integrative treatment of lung cancer, gastric cancer, breast cancer, and lymphoma; reversal of tumor drug resistance; mitigation of chemotherapy and radiotherapy toxicity; palliative care for advanced malignancy; and peri-chemotherapy integrative therapy.
Which hospital and department is Dr. Hou Li in?
Department of Hematology and Oncology at Dongzhimen Hospital
Sources
- Compiled from public information about the doctor's clinical title, department and areas of focus, rewritten by Find China Doctors.
- Medical licence: National Health Commission doctor registry
Dr. Hou Li has not reviewed this page. Request a correction or removal.
